OxyContin maker Purdue will stop selling doctors on opioids

Amid several lawsuits that accuse manufacturing giant Purdue Pharma of contributing to the country's opioid epidemic, the company announced Saturday it will cut sales staff by more than half...

==========
>> Sreenivasan: THIS WEEK, THEMAKER OF OXYCONTIN, ANNOUNCED ITIS ENDING ITS MARKETINGOPERATION FOR THE POWERFULOPIOID.PURDUE PHARMA IS NOT GIVING UPSELLING THE HIGHLY PROFITABLEDRUG, BUT IT WILL STOP SENDINGREPS TO DOCTORS OFFICES TO DRIVESALES OF THE ADDICTIVEPAINKILLER.BACK IN 2007, PURDUE PLEADEDGUILTY TO CRIMINAL CHARGES OFMISLEADING THE PUBLIC ABOUTOXYCONTIN'S ADDICTIVE QUALITIESAND AGREED TO A CIVIL PENALTY OFNEARLY $635 MILLION.THIS WEEK'S DECISION COMES ASPURDUE AND OTHER OPIOIDMANUFACTURERS ARE FACINGLAWSUITS FROM SOME 400 CITIESAND STATES ALLEGING THEY FUELEDADDICTION BY MISREPRESENTING THERISKS.COULD PURDUE'S MOVE CHANGE THECOURSE OF AMERICA'S OPIOIDCRISIS?LEV FACHER IS A REPORTER WITHSTAT NEWS AND JOINS ME FROMW...